Go Pro

Merit Financial Group LLC Raises Stock Position in Synopsys, Inc. $SNPS

Synopsys logo with Technology background
Image from MarketBeat Media, LLC.

Key Points

  • Merit Financial Group increased its Synopsys position by 15.5% in the second quarter, bringing its holdings to 25,247 shares valued at approximately $11.3 million. Institutional investors collectively own 85.47% of SNPS.
  • Synopsys exceeded quarterly expectations with earnings of $3.35 per share versus the $3.15 consensus and revenue of $2.28 billion, up 41.9% year over year. The company issued fiscal 2026 EPS guidance of $14.72–$14.80.
  • Analyst sentiment remains broadly positive, with a consensus “Moderate Buy” rating and a $565.06 price target, although the stock’s roughly 95 P/E ratio and broader semiconductor-cycle concerns present valuation and sector risks.
  • MarketBeat previews top five stocks to own in September.

Merit Financial Group LLC boosted its position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 15.5% in the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 25,247 shares of the semiconductor company's stock after acquiring an additional 3,392 shares during the period. Merit Financial Group LLC's holdings in Synopsys were worth $11,262,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently bought and sold shares of SNPS. Sankala Group LLC purchased a new position in Synopsys in the fourth quarter worth $25,000. Elevation Wealth Partners LLC lifted its holdings in shares of Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company's stock valued at $25,000 after purchasing an additional 27 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new stake in shares of Synopsys during the 4th quarter valued at $28,000. IMG Wealth Management Inc. acquired a new stake in shares of Synopsys in the 1st quarter worth $30,000. Finally, Atlas Capital Advisors Inc. purchased a new position in Synopsys during the 4th quarter worth $32,000. Hedge funds and other institutional investors own 85.47% of the company's stock.

Synopsys Stock Performance

Shares of SNPS stock opened at $411.75 on Friday. The firm has a market capitalization of $78.84 billion, a price-to-earnings ratio of 95.31, a price-to-earnings-growth ratio of 2.42 and a beta of 1.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. The business has a fifty day moving average of $426.49 and a 200 day moving average of $443.50. Synopsys, Inc. has a 1 year low of $366.00 and a 1 year high of $626.24.

Synopsys (NASDAQ:SNPS - Get Free Report) last posted its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating the consensus estimate of $3.15 by $0.20. The business had revenue of $2.28 billion for the quarter, compared to the consensus estimate of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The company's quarterly revenue was up 41.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, research analysts expect that Synopsys, Inc. will post 10.65 earnings per share for the current year.

Insider Buying and Selling

In other Synopsys news, CFO Shelagh Glaser sold 3,394 shares of the firm's stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares of the company's stock, valued at approximately $6,461,387.16. This trade represents a 19.12% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Sassine Ghazi sold 14,603 shares of the firm's stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the completion of the transaction, the chief executive officer directly owned 75,020 shares in the company, valued at $34,431,179.20. This represents a 16.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Corporate insiders own 0.56% of the company's stock.

Trending Headlines about Synopsys

Here are the key news stories impacting Synopsys this week:

Wall Street Analysts Forecast Growth

SNPS has been the topic of several recent analyst reports. Piper Sandler raised Synopsys from a "neutral" rating to an "overweight" rating and upped their target price for the company from $450.00 to $550.00 in a research report on Tuesday, June 23rd. KeyCorp restated an "overweight" rating on shares of Synopsys in a research note on Thursday, May 28th. Stifel Nicolaus upped their price objective on shares of Synopsys from $550.00 to $600.00 and gave the company a "buy" rating in a report on Thursday, May 28th. Morgan Stanley increased their price objective on shares of Synopsys from $480.00 to $525.00 and gave the company an "equal weight" rating in a research report on Thursday, May 28th. Finally, Weiss Ratings reiterated a "hold (c-)" rating on shares of Synopsys in a research note on Monday, June 8th. Two research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have issued a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $565.06.

Check Out Our Latest Research Report on Synopsys

Synopsys Company Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Featured Stories

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy Before the Robotics Revolution Cover

Robotics and automation are rapidly becoming essential infrastructure across healthcare, manufacturing, logistics, and many other industries.

"Physical AI" is coming to the United States, and there are four ways that investors can gain exposure to this new robotics revolution. Plus, learn which seven companies are most positioned to benefit as intelligent robots enter the workforce.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines